iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg(TM) and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023

MUNICH, Germany, March 15, 2023 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG, a biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, today announced that its high-throughput target discovery platform, myeloid iOTargTM, will be highlighted in an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023. Further, the company will present new data on its lead product candidate, OMX-0407, in a poster presentation at the conference, which will take place from April 14 to 19 in Orlando, Florida. The post iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg(TM) and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023 appeared first on Bio Tech Winners. [Image] Here are Some More Investing Tips and Resources. Enjoy! Sponsored [Bitcoin jumped 20% since the SVB news on Friday]( With the announcements of bank failures this week, now is the right time to jump into crypto. Bitcoin has jumped 20% since the SVB news on Friday. Joel Peterson scrambled to put together the best crypto team and they're hosting a webinar. They're going to reveal a "counterintuitive" 5-step system for generating totally automated profit in crypto...and how to leverage decentralized financing. You can set it up with a few clicks of a mouse and it will run 24/7 after that, banking profits for you on a dialy basis. [Click here for free registration now.]( [iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg(TM) and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023](?site= MUNICH, Germany, March 15, 2023 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG, a biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, today announced that its high-throughput target discovery platform, myeloid iOTargTM, will be highlighted in an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023. Further, the company will present new data on its lead product candidate, OMX-0407, in a poster presentation at the conference, which will take place from April 14 to 19 in Orlando, Florida. The post iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg(TM) and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023 appeared first on Bio Tech Winners. [Continue Reading...](?site= [iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg(TM) and New Data on SIK Checkpoint Inhibitor OMX-0407 at AACR 2023]( And, in case you missed it: - [Sofwave(TM) Granted FDA Clearance For Latest Innovation: The “Precise” SUPERB(TM) Applicator](?site= - [ADvantage Therapeutics Developing Therapies to Treat Neurodegenerative Conditions with Focus on Alzheimer’s Disease](?site= - [Episode #470: How To Invest in Timberland with AcreTrader’s Carter Malloy & Mark Foley](?site= - [Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023](?site= - [argenx Announces UK MHRA Approval of VYVGART for the Treatment of Generalized Myasthenia Gravis](?site= - FREE OR LOW COST INVESTING RESOURCES - [i]( [i]( [i]( [i]( Sponsored [Free Crypto Picks From Top Hedge Funds]( If you had caught this crypto event the first time…You could have made 12x on Bitcoin alone. We don't know what will happen this time around…But we do know a select group of cryptos are about to skyrocket. You DO NOT want to miss what's about to happen next. And you won't miss a thing, if you join us for…The Crypto Hedge Fund Summit. We've gathered 20+ of the world's most successful hedge fund managers. They will make a historic announcement during the event. [Click here for free registration now.]( [Privacy Policy/Disclosures]( - CLICK THE IMAGE BELOW FOR MORE INFORMATION - [i]( Good Investing! T. D. Thompson Founder & CEO [ProfitableInvestingTips.com]() ProfitableInvestingTips.com is an informational website for men and women who want to discover investing and trading products and strategies to educate themselves about the risks and benefits of investing and investing-related products. DISCLAIMER: Use of this Publisher's email, website and content, is subject to the Privacy Policy and Terms of Use published on Publisher's Website. Content marked as "sponsored" may be third party advertisements and are not endorsed or warranted by our staff or company. The content in our emails is for informational or entertainment use, and is not a substitute for professional advice. Always check with a qualified professional regarding investing and trading guidance. Be sure to do your own careful research before taking action based on anything you find in this content. If you no longer wish to receive our emails, click the link below: [Unsubscribe]( Net Wealth Consultants 6614 La Mora Drive Houston, Texas 77083 United States (888) 983-9123